PharmaCyte Biotech Inc (PMCB) — Working Capital to Net Assets Ratio
PharmaCyte Biotech Inc (PMCB) has a Working Capital to Net Assets ratio of 48.3% as of January 2026. Working capital of $19.02 Million (current assets of $20.70 Million minus current liabilities of $1.68 Million) is measured against net assets of $39.40 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See PMCB free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
PharmaCyte Biotech Inc Working Capital to Net Assets (2004–2025)
This chart shows how PharmaCyte Biotech Inc's Working Capital to Net Assets ratio has evolved across 22 annual periods from 2004 to 2025. As of January 2026, the ratio stands at 48.3%, reflecting working capital of $19.02 Million against net assets of $39.40 Million USD. See PharmaCyte Biotech Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for PharmaCyte Biotech Inc (2004–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for PharmaCyte Biotech Inc from 2004 to 2025, covering 22 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is PharmaCyte Biotech Inc worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 37.5% | $19.46 Million | $51.89 Million | $22.38 Million | $2.91 Million | ▼ -71.4 pp |
| 2024 | 108.9% | $43.02 Million | $39.51 Million | $50.44 Million | $7.42 Million | ▲ +15.9 pp |
| 2023 | 92.9% | $67.56 Million | $72.69 Million | $68.15 Million | $586.58K | ▼ -1.4 pp |
| 2022 | 94.3% | $84.79 Million | $89.92 Million | $85.49 Million | $704.37K | ▲ +71.1 pp |
| 2021 | 23.2% | $1.55 Million | $6.68 Million | $2.28 Million | $724.78K | ▲ +23.1 pp |
| 2020 | 0.1% | $6.25K | $5.09 Million | $1.04 Million | $1.03 Million | ▲ +1.9 pp |
| 2019 | -1.8% | $-89.45K | $5.04 Million | $653.40K | $742.85K | ▼ -12.9 pp |
| 2018 | 11.1% | $639.70K | $5.77 Million | $1.28 Million | $644.17K | ▼ -25.5 pp |
| 2017 | 36.6% | $2.96 Million | $8.09 Million | $3.54 Million | $580.25K | ▲ +15.2 pp |
| 2016 | 21.4% | $1.39 Million | $6.52 Million | $2.03 Million | $637.64K | ▲ +7.8 pp |
| 2015 | 13.6% | $806.58K | $5.94 Million | $2.82 Million | $2.01 Million | ▼ -29.1 pp |
| 2014 | 42.6% | $3.81 Million | $8.94 Million | $4.19 Million | $373.67K | ▼ -169.0 pp |
| 2013 | 211.6% | $-1.95 Million | $-921.46K | $1.85 Million | $3.80 Million | ▲ +92.0 pp |
| 2012 | 119.7% | $-2.73 Million | $-2.28 Million | $1.06 Million | $3.79 Million | ▼ -0.7 pp |
| 2011 | 120.4% | $-3.28 Million | $-2.73 Million | $104.75K | $3.39 Million | ▼ -35.4 pp |
| 2010 | 155.8% | $-3.04 Million | $-1.95 Million | $13.68K | $3.05 Million | ▲ +149.2 pp |
| 2009 | 6.6% | $263.94K | $3.99 Million | $1.18 Million | $918.80K | ▼ -41.2 pp |
| 2008 | 47.8% | $3.55 Million | $7.44 Million | $3.74 Million | $180.56K | ▼ -29.5 pp |
| 2007 | 77.3% | $3.31 Million | $4.29 Million | $3.43 Million | $118.81K | ▲ +8.8 pp |
| 2006 | 68.5% | $3.02 Million | $4.41 Million | $3.13 Million | $106.21K | ▲ +64.4 pp |
| 2005 | 4.1% | $-53.38K | $-1.30 Million | $244.06K | $297.45K | ▲ +89.1 pp |
| 2004 | -85.0% | $130.45K | $-153.43K | $130.71K | $260.00 | — |